Dominari (NASDAQ:DOMH) President Kyle Michael Wool Buys 50,000 Shares of Stock

Dominari Holdings Inc. (NASDAQ:DOMH) President Kyle Michael Wool bought 50,000 shares of the stock in a transaction dated Thursday, September 10th. The shares were purchased at an average price of $2.02 per share, with a total value of $101,000.00. Following the completion of the transaction, the president directly owned 4,261,828 shares in the company, valued at approximately $8,608,892.56. The trade was a 1.19% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

Dominari Stock Up 2.3%

Dominari stock opened at $2.23 on Tuesday. The company has a market cap of $54.06 million, a price-to-earnings ratio of -0.41 and a beta of 0.87. The firm’s fifty day moving average is $2.55 and its 200 day moving average is $2.92. Dominari Holdings Inc. has a 52-week low of $1.91 and a 52-week high of $8.40.

Dominari (NASDAQ:DOMH) last issued its quarterly earnings data on Monday, August 10th. The company reported ($0.21) EPS for the quarter, topping analysts’ consensus estimates of ($0.34) by $0.13. The business had revenue of $16.79 million during the quarter, compared to analysts’ expectations of $16.79 million. Dominari had a negative net margin of 51.61% and a negative return on equity of 235.37%.

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of the business. Creek Drive Management Group LLC purchased a new stake in shares of Dominari during the fourth quarter valued at $1,861,000. Connective Capital Management LLC raised its holdings in shares of Dominari by 112.9% in the second quarter. Connective Capital Management LLC now owns 243,223 shares of the company’s stock valued at $764,000 after acquiring an additional 128,994 shares in the last quarter. Renaissance Technologies LLC increased its position in Dominari by 59.1% during the 1st quarter. Renaissance Technologies LLC now owns 132,362 shares of the company’s stock valued at $430,000 after purchasing an additional 49,162 shares during the period. Finally, PFG Investments LLC increased its holdings in Dominari by 36.3% during the first quarter. PFG Investments LLC now owns 14,475 shares of the company’s stock valued at $47,000 after buying an additional 3,855 shares during the period. Hedge funds and other institutional investors own 42.48% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms have recently issued reports on DOMH. Wall Street Zen lowered Dominari from a “hold” rating to a “sell” rating in a research note on Saturday, August 15th. Weiss Ratings restated a “sell (d-)” rating on shares of Dominari in a report on Monday, July 6th. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the stock presently has an average rating of “Sell”.

About Dominari

Dominari Holdings Inc, a biotechnology company, focuses on developing small-molecule anticancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia. The company is also developing an antiviral platform that inhibits replication of viruses, including influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2.